Chan, Michele
Linn, Me Me Nay
O’Hagan, Thomas
Guerra-Assunção, José Afonso
Lackenby, Angie
Workman, Sarita
Dacre, Anna
Burns, Siobhan O.
Breuer, Judith
Hart, Jennifer
Tadros, Susan
Lowe, David M. http://orcid.org/0000-0001-6102-2375
Article History
Received: 5 December 2022
Accepted: 27 April 2023
First Online: 6 May 2023
Declarations
:
: The data collection protocol was approved by the Royal Free London COVID-19 oversight committee. Data were only derived from information collected as part of routine clinical care, were processed by the team providing direct care and are presented in fully anonymised form. No specific ethical approval is required for this collation or publication in line with National Health Service Health Research Authority guidance.
: SOB has received: research grant support from CSL Behring; personal fees or travel expenses from Immunodeficiency Canada/IAACI, CSL Behring, Glaxo SmithKline, Baxalta US Inc and Biotest. JB has received: research grants to her institution from GSK, Wellcome Trust, UKRI, Rosetrees Foundation and the John Black Foundation; consultancy fees (to institution) from GSK. ST has received: travel, accommodation and conference fees from CSL Behring. DML has received: research grants to his institution from LifeArc, Blood Cancer UK, Bristol Myers Squibb, GSK, British Society of Antimicrobial Chemotherapy and the UK Medical Research Council; speaker fees from Biotest and Gilead (educational video); travel, accommodation and conference fees from Octapharma; personal fees for a round-table discussion from Merck; consultancy fees (to institution) from GSK. All other authors report no competing interests.